From emerging threats to diagnostic breakthroughs: A strategic look ahead in AMR – Rebroadcast from ESCMID Global 2026 with live Q&A
Wednesday, May 27 at 16:00 BST | 17:00 CEST | 11:00 EDT | 08:00 PDT
This SelectScience® webinar features a rebroadcast from ESCMID Global 2026, followed by a live Q&A session. Brought to you by Danaher companies, Beckman Coulter Diagnostics and Cepheid, this session will explore the role of emerging diagnostic modalities to combat the development and spread of antimicrobial resistance (AMR).
The session will apply lessons learned from MRSA and VRE testing to emerging AMR threats such as CRE and C. auris. There will be an exploration of AMR gene detection using molecular methods such as syndromic PCR panels and NGS. Besides molecular methods, we will explore emerging rapid phenotypic antimicrobial susceptibility tests (AST) and bacterial versus viral host response-based diagnostics and their potential to improve antimicrobial stewardship and patient outcomes.
Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Webinar details
- Cost: Free to attend
- Location: Online
- Duration: 90 minutes
- Format: Rebroadcast of recorded symposium from ESCMID Global 2026 with live Q&A
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.
Speakers
Who should attend?
- Infectious disease and antimicrobial stewardship professionals
- Infection prevention and hospital epidemiology professionals
- Clinical microbiology professionals interested in molecular and rapid diagnostics, syndromic PCR, NGS, host response, and rapid phenotypic AST
- Researchers and translational scientists focused on AMR diagnostics and clinical impact
What will this webinar cover?
Cross-cutting themes will include innovation reviews, implementation challenges, and their impact on clinical microbiology, infectious disease, and stewardship programs in addressing AMR.
- Learn from early MDRO screening program successes and failures to improve the response to existing and emerging threats.
- Understand how current molecular approaches for detecting AMR genes can be used to improve clinical care.
- Assess the potential role of host-response diagnostics in distinguishing bacterial from viral infection, and evaluate factors influencing their implementation in support of antimicrobial stewardship.
- Compare current and emerging rapid phenotypic AST technologies and identify considerations for their clinical implementation and use.
